The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
Dr. Scott Gottlieb, Trump’s former FDA commissioner, said he has concerns about the president-elect’s pick for health ...
Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services immediately sent ...
Dr. Scott Gottlieb joins 'Fast Money' to talk how a Trump administration could impact the GLP-1 drug industry.
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
Scott Gottlieb, who served early on in Trump's first term, is now warning senators about the impact Kennedy could have on ...
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk Box' to discuss the incoming Trump ...
Scott Gottlieb, who served as commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first ...
Former FDA commissioner Scott Gottlieb came out against president-elect Trump’s choice of Robert F. Kennedy Jr. to lead the ...
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk Box' to discuss the incoming administration's picks for health cabinet positions, where Gottlieb's worries are, and much ...
WASHINGTON — Scott Gottlieb, who served as Food and Drug Administration commissioner in the first Trump administration, is raising concerns with Senate Republicans about the president-elect’s ...
Scott Gottlieb, who led the Food and Drug Administration during the Trump administration, on Friday warned that Robert F. Kennedy Jr. could “cost lives” if confirmed as the next secretary of ...